{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:04:09Z","timestamp":1794639849625,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471031"],"award-info":[{"award-number":["81471031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103272"],"award-info":[{"award-number":["82103272"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic & Clinical Sciences Integration Innovation Project of Xi\u2019an Jiaotong University","award":["YXJLRH2022018"],"award-info":[{"award-number":["YXJLRH2022018"]}],"id":[{"id":"https:\/\/ror.org\/017zhmm22","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["xzd012022099"],"award-info":[{"award-number":["xzd012022099"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Basic Research Program of Shaanxi","award":["2023-JC-ZD-47"],"award-info":[{"award-number":["2023-JC-ZD-47"]}]},{"name":"Natural Science Basic Research Program of Shaanxi","award":["2023-JC-QN-0921"],"award-info":[{"award-number":["2023-JC-QN-0921"]}]},{"name":"Research Project of Shaanxi Administration of Traditional Chinese Medicine","award":["SZY-KJCYC-2023-008"],"award-info":[{"award-number":["SZY-KJCYC-2023-008"]}],"id":[{"id":"https:\/\/ror.org\/027hagy81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) is one of the most common complications of type 2 diabetes mellitus (T2DM). The pathogenesis of NAFLD involves multiple biological changes, including insulin resistance, oxidative stress, inflammation, as well as genetic and environmental factors. Liraglutide has been used to control blood sugar. But the impact of liraglutide on T2DM-associated NAFLD remains unclear. In this study, we investigated the impact and potential molecular mechanisms of inhibiting ferroptosis for liraglutide improves T2DM-associated NAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Mice were fed on high-fat-diet and injected with streptozotocin to mimic T2DM-associated NAFLD and gene expression in liver was analysed by RNA-seq. The fast blood glucose was measured during the period of liraglutide and ferrostatin-1 administration. Hematoxylin and eosin staining was used to evaluate the pathological changes in the liver. The occurrence of hepatic ferroptosis was measured by lipid peroxidation in vivo. The mechanism of liraglutide inhibition ferroptosis was investigated by in vitro cell culture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Liraglutide not only improved glucose metabolism, but also ameliorated tissue damage in the livers. Transcriptomic analysis indicated that liraglutide regulates lipid metabolism related signaling including AMPK and ACC. Furthermore, ferroptosis inhibitor rather than other cell death inhibitors rescued liver cell viability in the presence of high glucose. Mechanistically, liraglutide-induced activation of AMPK phosphorylated ACC, while AMPK inhibitor compound C blocked the liraglutide-mediated suppression of ferroptosis. Moreover, ferroptosis inhibitor restored liver function in T2DM mice in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings indicate that liraglutide ameliorates the T2DM-associated NAFLD, which possibly through the activation of AMPK\/ACC pathway and inhibition of ferroptosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-023-00721-7","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T10:02:24Z","timestamp":1695895344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK\/ACC signaling and inhibiting ferroptosis"],"prefix":"10.1186","volume":"29","author":[{"given":"Tingli","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KeXin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuanzhuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4487-0863","authenticated-orcid":false,"given":"Lina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"issue":"3","key":"721_CR1","doi-asserted-by":"publisher","first-page":"e06358","DOI":"10.1016\/j.heliyon.2021.e06358","volume":"7","author":"K Alkethiri","year":"2021","unstructured":"Alkethiri K, Almtroudi T, Jurays AB, Abanumay F, Aldammas M, AlKhodheer M, et al. The relationship between type 2 diabetes mellitus with cognitive functions. Heliyon. 2021;7(3):e06358. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06358.","journal-title":"Heliyon."},{"issue":"2","key":"721_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/13543784.2020.1668374","volume":"29","author":"N Alkhouri","year":"2020","unstructured":"Alkhouri N, Lawitz E, Noureddin M, DeFronzo R, Shulman GI. GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH). Expert Opin Investig Drugs. 2020;29(2):135\u201341. https:\/\/doi.org\/10.1080\/13543784.2020.1668374.","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"721_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11064-021-03442-7","volume":"47","author":"JR An","year":"2022","unstructured":"An JR, Su JN, Sun GY, Wang QF, Fan YD, Jiang N, et al. Liraglutide alleviates cognitive deficit in db\/db mice: involvement in oxidative stress, iron overload, and ferroptosis. Neurochem Res. 2022;47(2):279\u201394. https:\/\/doi.org\/10.1007\/s11064-021-03442-7.","journal-title":"Neurochem Res"},{"key":"721_CR4","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12922","author":"P Anggreini","year":"2023","unstructured":"Anggreini P, Kuncoro H, Sumiwi SA, Levita J. Role of the AMPK\/SIRT1 pathway in non-alcoholic fatty liver disease (Review). Mol Med Rep. 2023. https:\/\/doi.org\/10.3892\/mmr.2022.12922.","journal-title":"Mol Med Rep"},{"key":"721_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2147\/ceg.S62831","volume":"7","author":"A Berlanga","year":"2014","unstructured":"Berlanga A, Guiu-Jurado E, Porras JA, Auguet T. Molecular pathways in non-alcoholic fatty liver disease. Clin Exp Gastroenterol. 2014;7:221\u201339. https:\/\/doi.org\/10.2147\/ceg.S62831.","journal-title":"Clin Exp Gastroenterol"},{"issue":"4","key":"721_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.ecl.2016.06.005","volume":"45","author":"F Bril","year":"2016","unstructured":"Bril F, Cusi K. Nonalcoholic fatty liver disease: the new complication of type 2 diabetes mellitus. Endocrinol Metab Clin North Am. 2016;45(4):765\u201381. https:\/\/doi.org\/10.1016\/j.ecl.2016.06.005.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"721_CR7","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1042\/bst0251232","volume":"25","author":"RW Brownsey","year":"1997","unstructured":"Brownsey RW, Zhande R, Boone AN. Isoforms of acetyl-CoA carboxylase: structures, regulatory properties and metabolic functions. Biochem Soc Trans. 1997;25(4):1232\u20138. https:\/\/doi.org\/10.1042\/bst0251232.","journal-title":"Biochem Soc Trans"},{"key":"721_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2022.2087595","author":"E Canbolat","year":"2022","unstructured":"Canbolat E, Cak\u0131roglu FP. The importance of AMPK in obesity and chronic diseases and the relationship of AMPK with nutrition: a literature review. Crit Rev Food Sci Nutr. 2022. https:\/\/doi.org\/10.1080\/10408398.2022.2087595.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"721_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","volume":"45","author":"D Carling","year":"2017","unstructured":"Carling D. AMPK signalling in health and disease. Curr Opin Cell Biol. 2017;45:31\u20137. https:\/\/doi.org\/10.1016\/j.ceb.2017.01.005.","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"721_CR10","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3892\/ijmm.2013.1453","volume":"32","author":"LN Chen","year":"2013","unstructured":"Chen LN, Lyu J, Yang XF, Ji WJ, Yuan BX, Chen MX, et al. Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in diabetic KKAy mice. Int J Mol Med. 2013;32(4):892\u2013900. https:\/\/doi.org\/10.3892\/ijmm.2013.1453.","journal-title":"Int J Mol Med"},{"issue":"2","key":"721_CR11","first-page":"213","volume":"53","author":"J Damanik","year":"2021","unstructured":"Damanik J, Yunir E. Type 2 diabetes mellitus and cognitive impairment. Acta Med Indones. 2021;53(2):213\u201320.","journal-title":"Acta Med Indones"},{"key":"721_CR12","doi-asserted-by":"publisher","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","volume":"1","author":"RA DeFronzo","year":"2015","unstructured":"DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1:15019. https:\/\/doi.org\/10.1038\/nrdp.2015.19.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"721_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"key":"721_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.970292","author":"C Fang","year":"2022","unstructured":"Fang C, Pan J, Qu N, Lei Y, Han J, Zhang J, et al. The AMPK pathway in fatty liver disease. Front Physiol. 2022. https:\/\/doi.org\/10.3389\/fphys.2022.970292.","journal-title":"Front Physiol"},{"issue":"7","key":"721_CR15","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/liv.15163","volume":"42","author":"G Feng","year":"2022","unstructured":"Feng G, Byrne CD, Targher G, Wang F, Zheng MH. Ferroptosis and metabolic dysfunction-associated fatty liver disease: is there a link? Liver Int. 2022;42(7):1496\u2013502. https:\/\/doi.org\/10.1111\/liv.15163.","journal-title":"Liver Int"},{"issue":"12","key":"721_CR16","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/nm.3372","volume":"19","author":"MD Fullerton","year":"2013","unstructured":"Fullerton MD, Galic S, Marcinko K, Sikkema S, Pulinilkunnil T, Chen ZP, et al. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat Med. 2013;19(12):1649\u201354. https:\/\/doi.org\/10.1038\/nm.3372.","journal-title":"Nat Med"},{"issue":"3","key":"721_CR17","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s11418-021-01491-4","volume":"75","author":"G Gao","year":"2021","unstructured":"Gao G, Xie Z, Li EW, Yuan Y, Fu Y, Wang P, et al. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1\/Nrf2-ARE signaling pathway to reduce ferroptosis. J Nat Med. 2021;75(3):540\u201352. https:\/\/doi.org\/10.1007\/s11418-021-01491-4.","journal-title":"J Nat Med"},{"issue":"4","key":"721_CR18","doi-asserted-by":"publisher","first-page":"e0214387","DOI":"10.1371\/journal.pone.0214387","volume":"14","author":"M Garcia-Jaramillo","year":"2019","unstructured":"Garcia-Jaramillo M, Spooner MH, L\u00f6hr CV, Wong CP, Zhang W. and Jump DB Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -\/- mice. PLoS ONE. 2019;14(4):e0214387. https:\/\/doi.org\/10.1371\/journal.pone.0214387.","journal-title":"PLoS ONE"},{"issue":"2","key":"721_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jhep.2020.04.001","volume":"73","author":"J Gautheron","year":"2020","unstructured":"Gautheron J, Gores GJ, Rodrigues CMP. Lytic cell death in metabolic liver disease. J Hepatol. 2020;73(2):394\u2013408. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.001.","journal-title":"J Hepatol"},{"key":"721_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jare.2022.06.003","volume":"46","author":"X Ge","year":"2023","unstructured":"Ge X, He X, Liu J, Zeng F, Chen L, Xu W, et al. Amelioration of type 2 diabetes by the novel 6, 8-guanidyl luteolin quinone-chromium coordination via biochemical mechanisms and gut microbiota interaction. J Adv Res. 2023;46:173\u201388. https:\/\/doi.org\/10.1016\/j.jare.2022.06.003.","journal-title":"J Adv Res"},{"issue":"5","key":"721_CR21","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1128\/mcb.01122-06","volume":"27","author":"N Harada","year":"2007","unstructured":"Harada N, Oda Z, Hara Y, Fujinami K, Okawa M, Ohbuchi K, et al. Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice. Mol Cell Biol. 2007;27(5):1881\u20138. https:\/\/doi.org\/10.1128\/mcb.01122-06.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"721_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19(2):121\u201335. https:\/\/doi.org\/10.1038\/nrm.2017.95.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"721_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","volume":"133","author":"T Hirschhorn","year":"2019","unstructured":"Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis. Free Radic Biol Med. 2019;133:130\u201343. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.09.043.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"721_CR24","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409\u201339. https:\/\/doi.org\/10.1152\/physrev.00034.2006.","journal-title":"Physiol Rev"},{"issue":"4","key":"721_CR25","doi-asserted-by":"publisher","first-page":"e3001197","DOI":"10.1371\/journal.pbio.3001197","volume":"19","author":"J Huang","year":"2021","unstructured":"Huang J, Zhao X, Li X, Peng J, Yang W. and Mi S HMGCR inhibition stabilizes the glycolytic enzyme PKM2 to support the growth of renal cell carcinoma. PLoS Biol. 2021;19(4):e3001197. https:\/\/doi.org\/10.1371\/journal.pbio.3001197.","journal-title":"PLoS Biol"},{"issue":"7","key":"721_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1586\/14779072.2015.1054810","volume":"13","author":"EW Iepsen","year":"2015","unstructured":"Iepsen EW, Torekov SS, Holst JJ. Liraglutide for type 2 diabetes and obesity: a 2015 update. Expert Rev Cardiovasc Ther. 2015;13(7):753\u201367. https:\/\/doi.org\/10.1586\/14779072.2015.1054810.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"721_CR27","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/bcpt.13082","volume":"123","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Rolin B, Rakipovski G, Skovsted GF, Madsen A, Kolstrup S, et al. Liraglutide decreases hepatic inflammation and injury in advanced lean non-alcoholic steatohepatitis. Basic Clin Pharmacol Toxicol. 2018;123(6):704\u201313. https:\/\/doi.org\/10.1111\/bcpt.13082.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"721_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-015-0693-3","volume":"16","author":"T Jorsal","year":"2016","unstructured":"Jorsal T, Rungby J, Knop FK, Vilsb\u00f8ll T. GLP-1 and amylin in the treatment of obesity. Curr Diab Rep. 2016;16(1):1. https:\/\/doi.org\/10.1007\/s11892-015-0693-3.","journal-title":"Curr Diab Rep"},{"key":"721_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18105227","author":"O Juanola","year":"2021","unstructured":"Juanola O, Mart\u00ednez-L\u00f3pez S, Franc\u00e9s R, G\u00f3mez-Hurtado I. Non-alcoholic fatty liver disease: metabolic, genetic, epigenetic and environmental risk factors. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph18105227.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"721_CR30","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2337\/diabetes.51.2.424","volume":"51","author":"CB Juhl","year":"2002","unstructured":"Juhl CB, Hollingdal M, Sturis J, Jakobsen G, Agers\u00f8 H, Veldhuis J, et al. Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes. Diabetes. 2002;51(2):424\u20139. https:\/\/doi.org\/10.2337\/diabetes.51.2.424.","journal-title":"Diabetes"},{"issue":"2","key":"721_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.2337\/db07-0381","volume":"57","author":"YD Kim","year":"2008","unstructured":"Kim YD, Park KG, Lee YS, Park YY, Kim DK, Nedumaran B, et al. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes. 2008;57(2):306\u201314. https:\/\/doi.org\/10.2337\/db07-0381.","journal-title":"Diabetes"},{"issue":"2","key":"721_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","volume":"22","author":"H Lee","year":"2020","unstructured":"Lee H, Zandkarimi F, Zhang Y, Meena JK, Kim J, Zhuang L, et al. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol. 2020;22(2):225\u201334. https:\/\/doi.org\/10.1038\/s41556-020-0461-8.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"721_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41392-020-00297-2","volume":"5","author":"C Li","year":"2020","unstructured":"Li C, Dong X, Du W, Shi X, Chen K, Zhang W, et al. LKB1-AMPK axis negatively regulates ferroptosis by inhibiting fatty acid synthesis. Signal Transduct Target Ther. 2020a;5(1):187. https:\/\/doi.org\/10.1038\/s41392-020-00297-2.","journal-title":"Signal Transduct Target Ther"},{"key":"721_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.freeradbiomed.2020.08.009","volume":"160","author":"N Li","year":"2020","unstructured":"Li N, Wang W, Zhou H, Wu Q, Duan M, Liu C, et al. Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury. Free Radic Biol Med. 2020b;160:303\u201318. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.08.009.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"721_CR35","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/hep.31856","volume":"74","author":"D Liu","year":"2021","unstructured":"Liu D, Pang J, Shao W, Gu J, Zeng Y, He HH, et al. Hepatic fibroblast growth factor 21 is involved in mediating functions of liraglutide in mice with dietary challenge. Hepatology. 2021;74(4):2154\u201369. https:\/\/doi.org\/10.1002\/hep.31856.","journal-title":"Hepatology"},{"issue":"5","key":"721_CR36","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/s0168-8278(01)00192-1","volume":"35","author":"C Loguercio","year":"2001","unstructured":"Loguercio C, De Girolamo V, de Sio I, Tuccillo C, Ascione A, Baldi F, et al. Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol. 2001;35(5):568\u201374. https:\/\/doi.org\/10.1016\/s0168-8278(01)00192-1.","journal-title":"J Hepatol"},{"issue":"1","key":"721_CR37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/1573402114666180507152620","volume":"15","author":"N Mikhail","year":"2019","unstructured":"Mikhail N. Cardiovascular effects of liraglutide. Curr Hypertens Rev. 2019;15(1):64\u20139. https:\/\/doi.org\/10.2174\/1573402114666180507152620.","journal-title":"Curr Hypertens Rev"},{"key":"721_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jnutbio.2018.07.009","volume":"62","author":"GV Moreira","year":"2018","unstructured":"Moreira GV, Azevedo FF, Ribeiro LM, Santos A, Guadagnini D, Gama P, et al. Liraglutide modulates gut microbiota and reduces NAFLD in obese mice. J Nutr Biochem. 2018;62:143\u201354. https:\/\/doi.org\/10.1016\/j.jnutbio.2018.07.009.","journal-title":"J Nutr Biochem"},{"issue":"5","key":"721_CR39","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1051\/medsci\/20163205016","volume":"32","author":"TM Nguyen","year":"2016","unstructured":"Nguyen TM, Froment P, Combarnous Y, Blesbois \u00c9. AMPK, regulator of sperm energy and functions. Med Sci (paris). 2016;32(5):491\u20136. https:\/\/doi.org\/10.1051\/medsci\/20163205016.","journal-title":"Med Sci (paris)"},{"key":"721_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/nu13061740","author":"Y Pang","year":"2021","unstructured":"Pang Y, Xu X, Xiang X, Li Y, Zhao Z, Li J, et al. High fat activates O-GlcNAcylation and affects AMPK\/ACC pathway to regulate lipid metabolism. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13061740.","journal-title":"Nutrients"},{"issue":"1","key":"721_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1210\/en.2012-1937","volume":"154","author":"N Panjwani","year":"2013","unstructured":"Panjwani N, Mulvihill EE, Longuet C, Yusta B, Campbell JE, Brown TJ, et al. GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-\/-) mice. Endocrinology. 2013;154(1):127\u201339. https:\/\/doi.org\/10.1210\/en.2012-1937.","journal-title":"Endocrinology"},{"key":"721_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/children4060046","author":"FM Perla","year":"2017","unstructured":"Perla FM, Prelati M, Lavorato M, Visicchio D, Anania C. The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease. Children (basel). 2017. https:\/\/doi.org\/10.3390\/children4060046.","journal-title":"Children (basel)."},{"issue":"9","key":"721_CR43","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1369\/0022155420946402","volume":"68","author":"MC Podszun","year":"2020","unstructured":"Podszun MC, Chung JY, Ylaya K, Kleiner DE, Hewitt SM, Rotman Y. 4-HNE immunohistochemistry and image analysis for detection of lipid peroxidation in human liver samples using vitamin E treatment in NAFLD as a proof of concept. J Histochem Cytochem. 2020;68(9):635\u201343. https:\/\/doi.org\/10.1369\/0022155420946402.","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"721_CR44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajpath.2019.09.011","volume":"190","author":"J Qi","year":"2020","unstructured":"Qi J, Kim JW, Zhou Z, Lim CW, Kim B. Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice. Am J Pathol. 2020;190(1):68\u201381. https:\/\/doi.org\/10.1016\/j.ajpath.2019.09.011.","journal-title":"Am J Pathol"},{"issue":"2","key":"721_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00109-016-1477-1","volume":"95","author":"A Salminen","year":"2017","unstructured":"Salminen A, Kauppinen A, Kaarniranta K. FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process. J Mol Med (berl). 2017;95(2):123\u201331. https:\/\/doi.org\/10.1007\/s00109-016-1477-1.","journal-title":"J Mol Med (berl)"},{"key":"721_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052764","author":"N Salvoza","year":"2022","unstructured":"Salvoza N, Giraudi PJ, Tiribelli C, Rosso N. Natural compounds for counteracting nonalcoholic fatty liver disease (NAFLD): advantages and limitations of the suggested candidates. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23052764.","journal-title":"Int J Mol Sci"},{"key":"721_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13578-019-0339-2","volume":"9","author":"D Sheng","year":"2019","unstructured":"Sheng D, Zhao S, Gao L, Zheng H, Liu W, Hou J, et al. BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling. Cell Biosci. 2019;9:77. https:\/\/doi.org\/10.1186\/s13578-019-0339-2.","journal-title":"Cell Biosci"},{"issue":"4","key":"721_CR48","doi-asserted-by":"publisher","first-page":"8334","DOI":"10.1080\/21655979.2022.2051858","volume":"13","author":"JX Song","year":"2022","unstructured":"Song JX, An JR, Chen Q, Yang XY, Jia CL, Xu S, et al. Liraglutide attenuates hepatic iron levels and ferroptosis in db\/db mice. Bioengineered. 2022a;13(4):8334\u201348. https:\/\/doi.org\/10.1080\/21655979.2022.2051858.","journal-title":"Bioengineered"},{"issue":"3","key":"721_CR49","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/cns.13791","volume":"28","author":"S Song","year":"2022","unstructured":"Song S, Guo R, Mehmood A, Zhang L, Yin B, Yuan C, et al. Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis-related NLRP3 pathway. CNS Neurosci Ther. 2022b;28(3):422\u201334. https:\/\/doi.org\/10.1111\/cns.13791.","journal-title":"CNS Neurosci Ther"},{"key":"721_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169309","author":"A Stancic","year":"2022","unstructured":"Stancic A, Velickovic K, Markelic M, Grigorov I, Saksida T, Savic N, et al. Involvement of ferroptosis in diabetes-induced liver pathology. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23169309.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"721_CR51","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401\u201321. https:\/\/doi.org\/10.1016\/j.cell.2022.06.003.","journal-title":"Cell"},{"issue":"1","key":"721_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","volume":"14","author":"H Tilg","year":"2017","unstructured":"Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14(1):32\u201342. https:\/\/doi.org\/10.1038\/nrgastro.2016.147.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"721_CR53","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","volume":"10","author":"S Tsurusaki","year":"2019","unstructured":"Tsurusaki S, Tsuchiya Y, Koumura T, Nakasone M, Sakamoto T, Matsuoka M, et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. Cell Death Dis. 2019;10(6):449. https:\/\/doi.org\/10.1038\/s41419-019-1678-y.","journal-title":"Cell Death Dis"},{"key":"721_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109870","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yu R, Wu L, Yang G. and Yang G Hydrogen sulfide guards myoblasts from ferroptosis by inhibiting ALOX12 acetylation. Cell Signal. 2021. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109870.","journal-title":"Cell Signal"},{"issue":"11","key":"721_CR55","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2174\/1389450123666220429082702","volume":"23","author":"D Wang","year":"2022","unstructured":"Wang D, Yang L, Liu Y. Targeting AMPK signaling in the liver: implications for obesity and type 2 diabetes mellitus. Curr Drug Targets. 2022a;23(11):1057\u201371. https:\/\/doi.org\/10.2174\/1389450123666220429082702.","journal-title":"Curr Drug Targets"},{"key":"721_CR56","doi-asserted-by":"publisher","first-page":"113374","DOI":"10.1016\/j.biopha.2022.113374","volume":"153","author":"S Wang","year":"2022","unstructured":"Wang S, Liu Z, Geng J, Li L, Feng X. An overview of ferroptosis in non-alcoholic fatty liver disease. Biomed Pharmacother. 2022b;153:113374. https:\/\/doi.org\/10.1016\/j.biopha.2022.113374.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"721_CR57","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12951-021-01058-1","volume":"19","author":"X Yao","year":"2021","unstructured":"Yao X, Xie R, Cao Y, Tang J, Men Y, Peng H, et al. Simvastatin induced ferroptosis for triple-negative breast cancer therapy. J Nanobiotechnology. 2021;19(1):311. https:\/\/doi.org\/10.1186\/s12951-021-01058-1.","journal-title":"J Nanobiotechnology"},{"key":"721_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.883057","author":"X Yi","year":"2022","unstructured":"Yi X, Yan W, Guo T, Liu N, Wang Z, Shang J, et al. Erythropoietin mitigates diabetic nephropathy by restoring PINK1\/parkin-mediated mitophagy. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.883057.","journal-title":"Front Pharmacol"},{"issue":"4","key":"721_CR59","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793\u2013801. https:\/\/doi.org\/10.1016\/j.jhep.2019.06.021.","journal-title":"J Hepatol"},{"issue":"1","key":"721_CR60","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41467-021-21841-w","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Swanda RV, Nie L, Liu X, Wang C, Lee H, et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun. 2021;12(1):1589. https:\/\/doi.org\/10.1038\/s41467-021-21841-w.","journal-title":"Nat Commun"},{"issue":"6478","key":"721_CR61","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1126\/science.aay0542","volume":"367","author":"P Zhao","year":"2020","unstructured":"Zhao P, Sun X, Chaggan C, Liao Z, In Wong K, He F, et al. An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis. Science. 2020;367(6478):652\u201360. https:\/\/doi.org\/10.1126\/science.aay0542.","journal-title":"Science"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00721-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-023-00721-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00721-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T02:34:53Z","timestamp":1700361293000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-023-00721-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["721"],"URL":"https:\/\/doi.org\/10.1186\/s10020-023-00721-7","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"23 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal care and experimental protocols were approved by the Ethics Committee on the Use and Care of Animals at Xi\u2019an Jiaotong University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}